Actelion shares gain on report of progress in Sanofi talks
ZURICH Swiss biotech group Actelion’s (ATLN.S) shares rose by more than 3 percent on Wednesday following a report that talks with Sanofi (SASY.PA) are making progress, increasing optimism that the two will strike a deal. Reuters reported late on Tuesday that discussions between the Swiss and French companies are progressing, despite investors’ fears that the Swiss biotech firm’s chief executive and founder might not want to sell. […]